Crowdonomics
WatchlistPortfolio
Throne Biotechnologies

Reg CF · Common Stock · Mar 2022

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$199.5K / $1M max
20% of ceiling · target hit day 1
Investors
102
$2K avg
Post-money valuation
$120.2M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$199K$100K$0
102510
Mar 1, 2022 · openedMay 1, 2022 · last reading
Target ($10K) hit — Mar 2, 2022, day 1Deadline Apr 30, 2022

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$0
−$497K
FY2019
$0
−$482K
FY2020
RevenueNet income
Metric
FY2019 reviewed
FY2020 reviewed
Income statement
Revenue
$0
$0
Cost of goods sold
$0
$0
Net income
-$496,520
-$482,168
Taxes paid
$0
$0
Balance sheet
Cash
$208,101
$59,519
Accounts receivable
$0
$0
Total assets
$2,619,727
$2,201,526
Short-term debt
$360,000
$360,000
Long-term debt
$383,699
$409,055
Total liabilities
$743,699
$769,055
Other
Headcount
—
5

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$120M
Post-money$120.2M
Price / share$7.59
Shares offered1,317

Perks

Invest $349+ and be eligible for StartEngine owner's 10% bonus program10% bonus$349+

Offering details

Target$9,996
Max$1,006,996
Min investment$349
OpenedMar 1, 2022
DeadlineApr 30, 2022
ClosedApr 30, 2022
Days active60

Links & provenance

Campaign pageSEC filingStartEngine listing
Source: Manual
0001665160-22-000346
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.